LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets hard-to-treat lung cancer in early trial
Disease control Recruiting nowThis early-phase study tests a targeted drug (trastuzumab deruxtecan) combined with immunotherapy, with or without chemotherapy, in people with advanced non-small cell lung cancer that has high levels of a protein called HER2. The main goal is to see if the combinations are safe …
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
New hope for advanced cancers: experimental drug targets tumors
Disease control Recruiting nowThis study tests an experimental drug called PF-07248144 in people with advanced or metastatic breast, prostate, or lung cancer that has not responded to standard treatments. The goal is to see if the drug is safe, tolerable, and can shrink or control tumors. About 320 participan…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New combo therapy aims to shrink lung tumors in phase 2 trial
Disease control Recruiting nowThis study tests a new drug called SHR2554, taken as a tablet, combined with other cancer treatments for people with advanced non-small cell lung cancer that has spread. The goal is to see if the combination is safe and can shrink tumors. About 200 adults aged 18-75 with good org…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New lung cancer pill enters human testing
Disease control Recruiting nowThis early-stage study tests a new tablet (AST2303) in 120 people with advanced non-small cell lung cancer that has spread. The main goals are to check the drug's safety and find the right dose, while also seeing if it can shrink tumors or slow the disease. Participants must have…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC